NCT00176033View on ClinicalTrials.gov

Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Conditions

HealthyPharmacokinetics

Trial Locations (1)

69120

Clinical Research Center, Department of Internal Medicine VI, Heidelberg

All Listed Sponsors

lead

Heidelberg University

OTHER

NCT00176033 - Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra | Biotech Hunter | Biotech Hunter